Clinical Research Advantage - AZ Maricopa, Phoenix 85050

Clinical Research Advantage entered the industry of Medical Labs in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5413802, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.

To acquire more information, please contact Royal Anspach, Partner by calling (480) 585-1790 during business hours. You can also write to the business’ Branch at 26224 North Tatum Boulevard # 15a, Phoenix, Arizona AZ 85050. You can also visit the company’s website at crastudies.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Clinical Research Advantage
Representative: Royal Anspach, Partner
Place of Business: 26224 North Tatum Boulevard # 15a, Phoenix, AZ 85050
Contact Number: (480) 585-1790
Website: crastudies.com
Type of Service: Medical Labs
SIC Number: 8071
NAICS Number: 5413802
Locality: Branch
Market Type: B2C (Business to Consumer)
Began: 2010
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Clinical Research Advantage is a company operating from Maricopa, Arizona providing professional Medical Labs and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 5413802 as Medical Labs.

With a current employee count of 1 to 4, Clinical Research Advantage has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Royal Anspach, Partner at (480) 585-1790 for related queries, or to locate its Branch using the coordinates 33.72536,-111.97754.

The Branch can also be found at the street address 26224 North Tatum Boulevard # 15a in Phoenix, Arizona 85050 and can be engaged online through the company website at crastudies.com, the company Twitter , and Facebook page .